This article might be an interesting read for the expert Paradigmers amongst you...or for anyone that would like to know a bit more about the joint U.S. Food and Drug Administration (FDA) / European Medicines Agency (EMA) application that Paradigm are in the process of making.
The FDA / EMA published a joint report on their efforts to support the development of and expedite access to breakthrough therapies that address unmet medical needs.
https://www.lexology.com/library/detail.aspx?g=85676a2f-f75a-43a7-8acc-8abf817a48e5
Good luck to all, Paradigmer as the news unfolds over the coming months
’
PAR -v- CUV, page-107
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $66.54M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.0¢ | $203.4K | 1.019M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 387930 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 65468 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |